Different breast cancer subtypes (Luminal A, Luminal B, Her2+, and TNBC) show unique immune cell types with distinct gene expressions, suggesting dynamic immune interactions with ER, PR and Her2 status between subtypes 5, which can further indicates differential prognosis6. The gene discussed is ERBB2; the disease is breast carcinoma.